Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT AUROBINDO PHARMA WOCKHARDT/
AUROBINDO PHARMA
 
P/E (TTM) x -5.6 12.8 - View Chart
P/BV x 0.9 1.1 77.4% View Chart
Dividend Yield % 0.0 1.9 -  

Financials

 WOCKHARDT   AUROBINDO PHARMA
EQUITY SHARE DATA
    WOCKHARDT
Mar-22
AUROBINDO PHARMA
Mar-22
WOCKHARDT/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs8051,064 75.6%   
Low Rs253584 43.3%   
Sales per share (Unadj.) Rs224.3400.3 56.0%  
Earnings per share (Unadj.) Rs-19.445.7 -42.4%  
Cash flow per share (Unadj.) Rs-2.264.9 -3.4%  
Dividends per share (Unadj.) Rs09.00 0.0%  
Avg Dividend yield %01.1 0.0%  
Book value per share (Unadj.) Rs266.0419.4 63.4%  
Shares outstanding (eoy) m144.03585.94 24.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.42.1 114.6%   
Avg P/E ratio x-27.318.0 -151.5%  
P/CF ratio (eoy) x-238.012.7 -1,875.8%  
Price / Book Value ratio x2.02.0 101.2%  
Dividend payout %019.7 0.0%   
Avg Mkt Cap Rs m76,168482,799 15.8%   
No. of employees `000NANA-   
Total wages/salary Rs m7,49034,509 21.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,300234,555 13.8%  
Other income Rs m2003,226 6.2%   
Total revenues Rs m32,500237,781 13.7%   
Gross profit Rs m1,15042,566 2.7%  
Depreciation Rs m2,47011,265 21.9%   
Interest Rs m2,990486 614.7%   
Profit before tax Rs m-4,11034,040 -12.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,3207,256 -18.2%   
Profit after tax Rs m-2,79026,784 -10.4%  
Gross profit margin %3.618.1 19.6%  
Effective tax rate %32.121.3 150.7%   
Net profit margin %-8.611.4 -75.6%  
BALANCE SHEET DATA
Current assets Rs m25,890181,227 14.3%   
Current liabilities Rs m32,07081,560 39.3%   
Net working cap to sales %-19.142.5 -45.0%  
Current ratio x0.82.2 36.3%  
Inventory Days Days3125 124.9%  
Debtors Days Days1062 16.6%  
Net fixed assets Rs m50,810155,104 32.8%   
Share capital Rs m720586 122.9%   
"Free" reserves Rs m37,590245,174 15.3%   
Net worth Rs m38,310245,760 15.6%   
Long term debt Rs m3,5502,492 142.5%   
Total assets Rs m76,700336,331 22.8%  
Interest coverage x-0.471.0 -0.5%   
Debt to equity ratio x0.10 913.8%  
Sales to assets ratio x0.40.7 60.4%   
Return on assets %0.38.1 3.2%  
Return on equity %-7.310.9 -66.8%  
Return on capital %-2.713.9 -19.2%  
Exports to sales %031.1 0.0%   
Imports to sales %1.911.9 16.2%   
Exports (fob) Rs mNA72,862 0.0%   
Imports (cif) Rs m62427,965 2.2%   
Fx inflow Rs m2,26377,245 2.9%   
Fx outflow Rs m62431,524 2.0%   
Net fx Rs m1,63845,721 3.6%   
CASH FLOW
From Operations Rs m4,13050,165 8.2%  
From Investments Rs m-2,010-32,116 6.3%  
From Financial Activity Rs m-710-29,693 2.4%  
Net Cashflow Rs m1,380-11,674 -11.8%  

Share Holding

Indian Promoters % 63.8 48.8 130.9%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 3.1 38.0 8.2%  
FIIs % 3.0 21.4 13.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.2 48.2 75.1%  
Shareholders   180,633 358,459 50.4%  
Pledged promoter(s) holding % 52.8 15.9 332.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on Wockhardt vs Aurobindo Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Wockhardt vs Aurobindo Pharma Share Price Performance

Period Wockhardt Aurobindo Pharma S&P BSE HEALTHCARE
1-Day -2.97% -0.06% -0.49%
1-Month -4.47% -16.41% -1.35%
1-Year -46.62% -29.68% -4.08%
3-Year CAGR -2.14% 1.48% 21.08%
5-Year CAGR -19.72% -6.55% 11.47%

* Compound Annual Growth Rate

Here are more details on the Wockhardt share price and the Aurobindo Pharma share price.

Moving on to shareholding structures...

The promoters of Wockhardt hold a 63.8% stake in the company. In case of Aurobindo Pharma the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Wockhardt and the shareholding pattern of Aurobindo Pharma.

Finally, a word on dividends...

In the most recent financial year, Wockhardt paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Aurobindo Pharma paid Rs 9.0, and its dividend payout ratio stood at 19.7%.

You may visit here to review the dividend history of Wockhardt, and the dividend history of Aurobindo Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

SGX Nifty Down 22 Points | Bharti Airtel's Big Launch | Rupee at 1-Month Low | Top Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets continued their downtrend throughout the session and ended marginally lower.